tiprankstipranks
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market

Castle Biosciences (CSTL) Income Statement

Compare
426 Followers

Castle Biosciences Income Statement

Last quarter (Q4 2024), Castle Biosciences's total revenue was $86.31M, an increase of 30.54% from the same quarter last year. In Q4, Castle Biosciences's net income was $9.59M. See Castle Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 332.07M$ 219.79M$ 137.04M$ 94.08M$ 62.65M
Gross Profit
$ 332.07M$ 174.81M$ 105.03M$ 78.26M$ 52.96M
Operating Expenses
$ 323.40M$ 242.78M$ 196.17M$ 118.34M$ 59.51M
Depreciation and Amortization
$ 16.00M$ 12.33M$ 10.54M$ 3.41M$ 472.00K
EBITDA
$ 38.14M$ -45.02M$ -58.34M$ -36.60M$ -7.09M
Operating Income
$ 8.67M$ -67.98M$ -91.14M$ -40.08M$ -6.54M
Other Income/Expenses
$ 12.89M$ 10.61M$ 3.95M$ 67.00K$ -3.66M
Pretax Income
$ 21.56M$ -57.37M$ -68.90M$ -40.01M$ -10.20M
Net Income
$ 18.25M$ -57.47M$ -67.14M$ -31.29M$ -10.28M
Per Share Metrics
Basic EPS
$ 0.66$ -2.14$ -2.58$ -1.24$ -0.54
Diluted EPS
$ 0.62$ -2.14$ -2.58$ -1.24$ -0.54
Weighted Average Shares Outstanding
27.78M 26.80M 26.05M 25.14M 18.93M
Weighted Average Shares Outstanding (Diluted)
29.25M 26.80M 26.05M 25.14M 18.93M
Currency in USD

Castle Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis